Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Christopher Striebich

Concepts (163)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
15
2026
1185
1.200
Why?
Antirheumatic Agents
4
2026
309
0.630
Why?
Hydroxychloroquine
2
2026
65
0.440
Why?
Anti-Citrullinated Protein Antibodies
3
2026
129
0.360
Why?
Susac Syndrome
1
2011
3
0.330
Why?
Pregnancy Complications, Cardiovascular
1
2011
83
0.320
Why?
B-Lymphocytes
4
2025
887
0.280
Why?
Rheumatoid Factor
4
2022
177
0.250
Why?
Interferon-alpha
2
2021
201
0.250
Why?
Lupus Erythematosus, Systemic
2
2025
241
0.240
Why?
Autoantibodies
6
2023
1500
0.240
Why?
Endothelium, Vascular
1
2011
952
0.210
Why?
Meniscus
1
2023
23
0.190
Why?
Rheumatology
1
2023
136
0.180
Why?
Autoimmune Diseases
2
2019
467
0.160
Why?
Receptors, Antigen, T-Cell, alpha-beta
2
2002
330
0.160
Why?
Disease Progression
2
2025
2867
0.160
Why?
STAT1 Transcription Factor
1
2021
68
0.160
Why?
Anterior Cruciate Ligament Injuries
1
2023
218
0.160
Why?
Lovastatin
1
2020
37
0.160
Why?
Methotrexate
2
2021
234
0.150
Why?
Osteoarthritis, Knee
1
2023
291
0.150
Why?
STAT3 Transcription Factor
1
2021
214
0.140
Why?
Interleukin-10
1
2021
310
0.140
Why?
Synovial Fluid
1
1998
69
0.140
Why?
C-Reactive Protein
1
2020
429
0.130
Why?
Arthroplasty, Replacement, Knee
1
2023
385
0.130
Why?
Rheumatic Diseases
1
2019
101
0.130
Why?
T-Lymphocytes
1
2025
2012
0.120
Why?
CD4-Positive T-Lymphocytes
2
2025
1150
0.120
Why?
Triage
1
2019
243
0.120
Why?
Fatty Acids, Omega-3
1
2017
145
0.120
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2020
449
0.120
Why?
Autoimmunity
2
2012
925
0.120
Why?
Interferon-beta
1
2015
90
0.110
Why?
Inflammation
2
2025
2919
0.110
Why?
Epitopes
3
2023
479
0.110
Why?
Double-Blind Method
3
2026
2070
0.110
Why?
Wrist Injuries
1
2014
23
0.100
Why?
Ligaments, Articular
1
2014
56
0.100
Why?
Antibodies, Monoclonal, Murine-Derived
2
2011
96
0.100
Why?
Peptides, Cyclic
3
2026
276
0.100
Why?
Middle Aged
13
2026
36619
0.100
Why?
Rituximab
2
2011
208
0.090
Why?
Adult
11
2026
41087
0.090
Why?
Stress, Psychological
1
2020
1171
0.090
Why?
Range of Motion, Articular
1
2014
446
0.090
Why?
Bronchial Diseases
1
2011
38
0.090
Why?
Treatment Outcome
6
2025
11821
0.090
Why?
Muscle Strength
1
2014
340
0.080
Why?
Humans
22
2026
146342
0.080
Why?
Female
16
2026
79499
0.080
Why?
Labor, Induced
1
2011
41
0.080
Why?
Tumor Necrosis Factor-alpha
1
2015
1224
0.080
Why?
Cyclophosphamide
1
2011
275
0.080
Why?
Genes, Immunoglobulin
1
1990
29
0.080
Why?
Severity of Illness Index
3
2025
2921
0.080
Why?
Immunoglobulins, Intravenous
1
2011
134
0.080
Why?
Immune Tolerance
1
2012
386
0.080
Why?
Recovery of Function
1
2014
725
0.080
Why?
Health Fairs
1
2009
10
0.080
Why?
Immunoglobulin Heavy Chains
1
1990
83
0.080
Why?
Male
15
2026
73396
0.080
Why?
Synovitis
1
2009
35
0.070
Why?
Signal Transduction
2
2021
5246
0.070
Why?
Drug Therapy, Combination
1
2011
1036
0.070
Why?
Adrenal Cortex Hormones
1
2011
486
0.070
Why?
Risk Factors
4
2025
10921
0.060
Why?
Aspirin
1
2011
405
0.060
Why?
Immunoglobulin M
2
2022
284
0.060
Why?
Antibodies, Antinuclear
1
2025
60
0.060
Why?
Biomarkers
4
2021
4340
0.050
Why?
Lung Diseases
1
2011
787
0.050
Why?
Aged
6
2026
26432
0.050
Why?
Rheumatologists
1
2023
15
0.050
Why?
Immunosuppressive Agents
1
2008
829
0.050
Why?
Phosphorylation
2
2021
1724
0.050
Why?
Immunoglobulin Isotypes
1
2022
36
0.050
Why?
Complementarity Determining Regions
1
2002
54
0.050
Why?
Colorado
3
2020
4595
0.040
Why?
Clone Cells
2
2002
259
0.040
Why?
Incidence
2
2020
2936
0.040
Why?
Leukocytes, Mononuclear
2
2021
585
0.040
Why?
Prospective Studies
3
2022
8123
0.040
Why?
Mass Screening
1
2009
1307
0.040
Why?
Immunoglobulin A
1
2022
205
0.040
Why?
Abatacept
1
2021
56
0.040
Why?
Antibodies, Monoclonal
1
2008
1512
0.040
Why?
Epigenesis, Genetic
1
2025
712
0.040
Why?
Young Adult
4
2025
14330
0.040
Why?
Complement Activation
1
2023
412
0.040
Why?
Joints
2
2011
107
0.040
Why?
Sequence Analysis
1
1998
32
0.040
Why?
Amino Acid Sequence
2
2002
2092
0.040
Why?
Lymphocyte Activation
1
2002
1137
0.030
Why?
Molecular Sequence Data
2
2002
2838
0.030
Why?
Pregnancy
1
2011
7230
0.030
Why?
HIV-1
1
2002
913
0.030
Why?
CD8-Positive T-Lymphocytes
1
2002
931
0.030
Why?
Aged, 80 and over
2
2021
8391
0.030
Why?
Base Sequence
1
1998
2123
0.030
Why?
Odds Ratio
1
2017
1077
0.030
Why?
Patient Selection
1
2019
728
0.030
Why?
Lunate Bone
1
2014
12
0.030
Why?
Scaphoid Bone
1
2014
19
0.030
Why?
Survival Analysis
1
2017
1378
0.030
Why?
Proportional Hazards Models
1
2017
1331
0.030
Why?
Adolescent
3
2025
22557
0.020
Why?
Case-Control Studies
1
2021
3647
0.020
Why?
Syk Kinase
1
2012
19
0.020
Why?
Immunoglobulin D
1
2012
30
0.020
Why?
Longitudinal Studies
1
2020
3017
0.020
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 7
1
2012
30
0.020
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 11
1
2012
23
0.020
Why?
Clonal Anergy
1
2012
55
0.020
Why?
Arthrography
1
2011
19
0.020
Why?
Receptors, Antigen, B-Cell
1
2012
134
0.020
Why?
Cross-Sectional Studies
1
2023
5899
0.020
Why?
Antigens, CD19
1
2012
137
0.020
Why?
Risk Assessment
1
2020
3712
0.020
Why?
Cell Differentiation
1
1998
1982
0.020
Why?
Sensitivity and Specificity
1
2015
1998
0.020
Why?
Retrospective Studies
2
2022
17438
0.020
Why?
Predictive Value of Tests
1
2015
2113
0.020
Why?
Blotting, Northern
1
1990
197
0.020
Why?
Immunoglobulin Variable Region
1
1990
78
0.020
Why?
Cross Reactions
1
1990
130
0.020
Why?
Hybridomas
1
1990
233
0.020
Why?
Antibody Specificity
1
1990
181
0.020
Why?
Molecular Weight
1
1990
295
0.020
Why?
Databases, Factual
1
2015
1493
0.020
Why?
Autoantigens
1
2012
426
0.020
Why?
Mice, Mutant Strains
1
1990
290
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2012
429
0.020
Why?
Intracellular Signaling Peptides and Proteins
1
2012
457
0.020
Why?
Protein-Tyrosine Kinases
1
2012
429
0.020
Why?
Seroepidemiologic Studies
1
2009
171
0.020
Why?
Multigene Family
1
1990
210
0.020
Why?
Community-Institutional Relations
1
2009
101
0.020
Why?
Structure-Activity Relationship
1
1990
563
0.020
Why?
Early Diagnosis
1
2009
251
0.020
Why?
Antigens, CD20
1
2008
34
0.020
Why?
Follow-Up Studies
1
2017
5439
0.020
Why?
Lymphocyte Count
1
2008
167
0.020
Why?
Lymphocyte Depletion
1
2008
135
0.020
Why?
Prognosis
1
2015
4351
0.020
Why?
HIV Infections
1
2002
3215
0.020
Why?
Registries
1
2015
2400
0.020
Why?
Gene Expression
1
1990
1463
0.010
Why?
United States
1
2022
16136
0.010
Why?
Tomography, X-Ray Computed
1
2014
2786
0.010
Why?
Genes, T-Cell Receptor beta
1
2002
22
0.010
Why?
Cytotoxicity, Immunologic
1
2002
224
0.010
Why?
Reproducibility of Results
1
2009
3416
0.010
Why?
T-Lymphocyte Subsets
1
2002
416
0.010
Why?
Sequence Analysis, DNA
1
2002
771
0.010
Why?
Flow Cytometry
1
2002
1163
0.010
Why?
Surveys and Questionnaires
1
2009
6073
0.010
Why?
Mice
1
1990
18297
0.010
Why?
Infant
1
2002
10114
0.000
Why?
Animals
1
1990
38107
0.000
Why?
Child, Preschool
1
2002
11913
0.000
Why?
Child
1
2002
22693
0.000
Why?
Striebich's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)